| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Aisling Capital Iv, LP serves as a 10% Owner at VIRX. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $6.1M at current prices.
The biggest single holding is VIRX (~$6.1M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 2,500,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2019 | VIRX Viracta Therapeutics, Inc. | 10% Owner | Buy | 2,500,000 | $0.60 | $1,500,000.00 | +32.9% |